Mirxes Raises HK$673 Million Through Completion of New Share Placing

Mirxes Holding Company Limited ( (HK:2629) ) has provided an announcement.

Mirxes Holding Company Limited has completed a placing of 21,888,000 new shares under its general mandate, issuing the shares at HK$32.50 each through joint placing agents to at least six independent investors. The transaction, which closed on 5 February 2026, raised gross proceeds of approximately HK$711.36 million and net proceeds of about HK$673.43 million, implying a net price of roughly HK$30.77 per share; following the issuance, the company’s total share capital increased from 276,342,331 to 298,230,331 shares, diluting existing shareholders’ stakes while introducing new institutional or professional investors holding 7.34% of the enlarged share capital, thereby strengthening Mirxes’ capital base for future development and potentially enhancing its market position.

More about Mirxes Holding Company Limited

Mirxes Holding Company Limited is a Cayman Islands–incorporated company listed on the Hong Kong Stock Exchange (Stock Code: 2629). The company operates in the broader life sciences and biotechnology sector, with its business centered on genetic and molecular diagnostics solutions, targeting healthcare and medical markets that require advanced testing technologies.

Average Trading Volume: 756,339

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$8.42B

Learn more about 2629 stock on TipRanks’ Stock Analysis page.